参考文献:1. Armstrong R. A., Cairns N. J., and Lantos P. L. (2001) Spatial pattern of prion protein deposits in patients with sporadic Creutzfeldt-Jakob disease. / Neuropathology 1, 19-4. CrossRef 2. Bartolini M., Bertucci C., Cavrini V., and Andrisano V. (2003) β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. / Biochem. Pharmacol. 65, 407-16. CrossRef 3. Camps P., El Achab R., Gorbic D. M., Morral J., Mu?oz-Torrero D., Badia A., et al. (1999) Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease. / J. Med. Chem. 42, 3227-242. CrossRef 4. Hainfellner J. A., Wanschitz J., Jellinger K., Liberski P. P., Gullotta F., and Budka H. (1998) Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. / Acta Neuropathol. (Berl.) 96, 116-22. CrossRef 5. Inestrosa N. C., álvarez A., Perez C. A., Moreno R. D., Vicente M., Linker C., et al. (1996) Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. / Neuron 16, 881-91. CrossRef 6. Tateishi J., Kitamoto T., Hashiguchi H., and Shii H. (1988) Gerstmann-Straussler-Scheinker disease: immunohistological and experimental studies. / Ann. Neurol. 24, 35-0. CrossRef
作者单位:M. V. Clos (1) M. Pera (1) M. Ratia (1) S. Román (1) P. Camps (2) D. Mu?oz-Torrero (2) L. Colombo (3) M. Salmona (3) A. Badia (1)
1. Departamento de Farmacologia, de Terapèutica, i de Toxicologia, Instituto Neurociències, UAB, Barcelona, Spain 2. Laboratori de Química Farmacèutica, Facultat de Farmàcia, UB, Barcelona, Spain 3. Laboratorio di Chimica e Biochimica delle Proteine, 1st di Recerche Farmacologiche Mario Negri, Milan, Italy